The Yellow Card scheme is MHRA's national reporting route for suspected adverse reactions and other safety problems involving medicines and healthcare products.
Core official resource
- Yellow Card — online reporting and safety-information access.
Practical use
The Yellow Card site is the public-facing reporting system. Marketing-authorisation holders should not assume that submission of a Yellow Card replaces their own statutory pharmacovigilance reporting obligations; company reporting requirements must be followed through the applicable MHRA pharmacovigilance procedures and electronic reporting arrangements.